Mark Wingertzahn
Chief Tech/Sci/R&D Officer at WESANA HEALTH HOLDINGS INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Daniel Carcillo | M | - | - | |
| Kevin Silva | M | 70 |
New York Institute of Technology
| 17 years |
| Charlene DeGregoria | F | - |
New York Institute of Technology
| 14 years |
| George Michael Steinbrenner | M | 27 | - | |
| Mitchell Kahn | M | 63 | - | |
| Charanjit Bountra | M | 63 |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | - |
| Santhosh Keshavan | M | 50 |
New York Institute of Technology
| - |
| Ian Burnstein | M | 54 | 3 years | |
| Xian Fang Liu | M | 71 |
New York Institute of Technology
| 27 years |
| Tom Bianculli | M | - |
New York Institute of Technology
| - |
| Peter A. Ferentinos | M | - |
New York Institute of Technology
| - |
| Paul Lirette | M | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | 36 years |
| Alan Guarino | M | 64 |
New York Institute of Technology
| - |
| Yong Biao Ding | M | - | 1 years | |
| Ken Batchelor | M | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | - |
| Robert Evanson | M | 87 |
New York Institute of Technology
| - |
| Melissa Karp Smith | F | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | - |
| V. Michael Mavaddat | M | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | - |
| Philip Fasano | M | 65 |
New York Institute of Technology
| - |
| Andrew Witty | M | 59 |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | - |
| Michael J. Merlo | M | 76 |
New York Institute of Technology
| - |
| Ruth Kemp | F | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | - |
| Lee S. Simonson | M | 75 |
New York Institute of Technology
| 22 years |
| Christopher Gent | M | 75 |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | - |
| Rich Daly | M | 71 |
New York Institute of Technology
| - |
| Monte N. Redman | M | 72 |
New York Institute of Technology
| - |
| Alexander Kaganowicz | M | 77 |
New York Institute of Technology
| - |
| Cristina L. Mendoza | F | 77 |
New York Institute of Technology
| - |
| Jun Ma | M | 60 |
New York Institute of Technology
| 31 years |
| Robert Koffman | M | - | - |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 22 | 73.33% |
| Canada | 8 | 26.67% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Mark Wingertzahn
- Personal Network
